Agreement 0 9 0 9 B-contraception_consent
to 10 12 10 12 I-contraception_consent
use 13 16 13 16 I-contraception_consent
highly 17 23 17 23 I-contraception_consent
effective 24 33 24 33 I-contraception_consent
forms 34 39 34 39 I-contraception_consent
of 40 42 40 42 I-contraception_consent
contraception 43 56 43 56 I-contraception_consent
during 57 63 57 63 O
the 64 67 64 67 O
study 68 73 68 73 O
and 74 77 74 77 O
6 78 79 78 79 B-upper_bound
months 80 86 80 86 I-upper_bound
after 87 92 87 92 O
the 93 96 93 96 O
last 97 101 97 101 O
dose 102 106 102 106 O
of 107 109 107 109 O
bendamustine 110 122 110 122 B-treatment
, 122 123 122 123 O
or 124 126 124 126 O
12 127 129 127 129 B-upper_bound
months 130 136 130 136 I-upper_bound
after 137 142 137 142 O
the 143 146 143 146 O
last 147 151 147 151 O
dose 152 156 152 156 O
of 157 159 157 159 O
rituximab 160 169 160 169 B-treatment
, 169 170 169 170 O
whichever 171 180 171 180 O
is 181 183 181 183 O
longest 184 191 184 191 O

Eastern 0 7 192 199 B-clinical_variable
Cooperative 8 19 200 211 I-clinical_variable
Oncology 20 28 212 220 I-clinical_variable
Group 29 34 221 226 I-clinical_variable
( 35 36 227 228 I-clinical_variable
ECOG 36 40 228 232 I-clinical_variable
) 40 41 232 233 I-clinical_variable
performance 42 53 234 245 I-clinical_variable
status 54 60 246 252 I-clinical_variable
of 61 63 253 255 O
â‰¤ 64 65 256 257 O
2 66 67 258 259 B-upper_bound

MCL 0 3 260 263 O
requiring 4 13 264 273 O
treatment 14 23 274 283 B-treatment
and 24 27 284 287 O
for 28 31 288 291 O
which 32 37 292 297 O
no 38 40 298 300 O
prior 41 46 301 306 O
systemic 47 55 307 315 B-treatment
anticancer 56 66 316 326 I-treatment
therapies 67 76 327 336 I-treatment
have 77 81 337 341 O
been 82 86 342 346 O
received 87 95 347 355 O

Men 0 3 356 359 B-gender

Pathologically 0 14 360 374 O
confirmed 15 24 375 384 O
MCL 25 28 385 388 B-cancer
, 28 29 388 389 O
with 30 34 390 394 O
documentation 35 48 395 408 O
of 49 51 409 411 O
a 52 53 412 413 O
chromosome 54 64 414 424 O
translocation 65 78 425 438 O
t(11;14)(q13;q32 79 95 439 455 O
) 95 96 455 456 O
and/or 97 103 457 463 O
overexpression 104 118 464 478 O
of 119 121 479 481 O
cyclin 122 128 482 488 O
D1 129 131 489 491 O
in 132 134 492 494 O
association 135 146 495 506 O
with 147 151 507 511 O
other 152 157 512 517 O
relevant 158 166 518 526 O
markers 167 174 527 534 O
( 175 176 535 536 O
eg 176 178 536 538 O
, 178 179 538 539 O
CD5 180 183 540 543 O
, 183 184 543 544 O
CD19 185 189 545 549 O
, 189 190 549 550 O
CD20 191 195 551 555 O
, 195 196 555 556 O
PAX5 197 201 557 561 O
) 201 202 561 562 O

Significant 0 11 563 574 O
cardiovascular 12 26 575 589 B-chronic_disease
disease 27 34 590 597 I-chronic_disease
such 35 39 598 602 O
as 40 42 603 605 O
uncontrolled 43 55 606 618 O
or 56 58 619 621 O
symptomatic 59 70 622 633 B-chronic_disease
arrhythmias 71 82 634 645 I-chronic_disease
, 82 83 645 646 O
congestive 84 94 647 657 B-chronic_disease
heart 95 100 658 663 I-chronic_disease
failure 101 108 664 671 I-chronic_disease
, 108 109 671 672 O
or 110 112 673 675 O
myocardial 113 123 676 686 B-chronic_disease
infarction 124 134 687 697 I-chronic_disease
within 135 141 698 704 O
6 142 143 705 706 B-upper_bound
months 144 150 707 713 I-upper_bound
of 151 153 714 716 O
first 154 159 717 722 O
dose 160 164 723 727 O
of 165 167 728 730 O
study 168 173 731 736 O
drug 174 178 737 741 O
, 178 179 741 742 O
or 180 182 743 745 O
any 183 186 746 749 O
Class 187 192 750 755 B-chronic_disease
3 193 194 756 757 I-chronic_disease
or 195 197 758 760 I-chronic_disease
4 198 199 761 762 I-chronic_disease
cardiac 200 207 763 770 I-chronic_disease
disease 208 215 771 778 I-chronic_disease
as 216 218 779 781 O
defined 219 226 782 789 O
by 227 229 790 792 O
the 230 233 793 796 O
New 234 237 797 800 O
York 238 242 801 805 O
Heart 243 248 806 811 O
Association 249 260 812 823 O
Functional 261 271 824 834 O
Classification 272 286 835 849 O
, 286 287 849 850 O
or 288 290 851 853 O
corrected 291 300 854 863 O
QT 301 303 864 866 B-clinical_variable
interval 304 312 867 875 I-clinical_variable
( 313 314 876 877 I-clinical_variable
QTc 314 317 877 880 I-clinical_variable
) 317 318 880 881 I-clinical_variable
> 319 320 882 883 O
480 321 324 884 887 B-lower_bound
msec 325 329 888 892 I-lower_bound
( 330 331 893 894 O
calculated 331 341 894 904 O
using 342 347 905 910 O
Friderica 348 357 911 920 O
's 357 359 920 922 O
formula 360 367 923 930 O
: 367 368 930 931 O
QT 369 371 932 934 O
/ 371 372 934 935 O
RR0.33 372 378 935 941 O
) 378 379 941 942 O
at 380 382 943 945 O
screening 383 392 946 955 O

